Submucosal Injection of Stabilized Nonanimal Hyaluronic Acid with Dextranomer
- 1 June 2009
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Diseases of the Colon & Rectum
- Vol. 52 (6), 1101-1106
- https://doi.org/10.1007/dcr.0b013e31819f5cbf
Abstract
NASHA Dx gel has been used extensively for treatments in the field of urology. This study was performed to evaluate NASHA Dx gel as an injectable anal canal implant for the treatment of fecal incontinence. Thirty-four patients (5 males, 29 females; median age, 61 years; range, 34 to 80) were injected with 4 x 1 ml of NASHA Dx gel, just above the dentate line in the submucosal layer. The primary end point was change in the number of incontinence episodes and a treatment response was defined as a 50 percent reduction compared with pretreatment. All patients were followed up at 3, 6, and 12 months. The median number of incontinence episodes during four weeks was 22 (range, 2 to 77) before treatment, at 6 months it was 9 (range, 0 to 46), and at 12 months it was 10 (range, 0 to 70, P = 0.004). Fifteen patients (44 percent) were responders at 6 months, compared with 19 (56 percent) at 12 months. No long-term side effects or serious adverse events were reported. Submucosal injection of NASHA Dx gel is an effective treatment for fecal incontinence. The effect is sustained for at least 12 months. The treatment is associated with low morbidity.Keywords
This publication has 13 references indexed in Scilit:
- Carbon-Coated Microbeads Anal Injection in Outpatient Treatment of Minor Fecal IncontinenceDiseases of the Colon & Rectum, 2008
- Treatment of Vesicoureteral Reflux Using Endoscopic Injection of Nonanimal Stabilized Hyaluronic Acid/Dextranomer Gel: Initial Experience in Pediatric Patients by a Single SurgeonPediatrics, 2006
- An Open, Multicentre Study of NASHA/Dx Gel (Zuidex™) for the Treatment of Stress Urinary IncontinenceEuropean Urology, 2005
- Injectable bulking agents for treating faecal incontinenceBritish Journal of Surgery, 2005
- Injectable Silicone Biomaterial for Fecal Incontinence Caused by Internal Anal Sphincter Dysfunction Is EffectiveDiseases of the Colon & Rectum, 2004
- Endoscopic Treatment with Dextranomer-Hyaluronic Acid for Vesicoureteral Reflux: Histological FindingsJournal of Urology, 2003
- Endoanal ultrasound or magnetic resonance imaging for preoperative assessment of anal fistula: a comparative studyColorectal Disease, 2001
- Injectable Dextranomer-based Implant: Histopathology, Volume Changes and DNA-analysisScandinavian Journal of Urology and Nephrology, 1999
- Evaluation of a Questionnaire in the Assessment of Patients with Faecal Incontinence and ConstipationScandinavian Journal of Gastroenterology, 1996
- Prospective study of conservative and operative treatment for faecal incontinenceBritish Journal of Surgery, 1988